Join
Live feed
·
INSIDERFilingvia Quantisnow
Windtree Therapeutics Inc. logo

SEC Form 4: Geffken Daniel E. was granted 2,033 shares, increasing direct ownership by 1,432% to 2,175 units

ByQuantisnow·Wall Street's wire, on your screen.
WINT· Windtree Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track WINT (Windtree Therapeutics Inc.) and more on Quantisnow.